{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:07:47Z","timestamp":1792876067788,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>In light of the vulnerability of the developing brain, mixture risk assessment (MRA) for the evaluation of developmental neurotoxicity (DNT) should be implemented, since infants and children are co-exposed to more than one chemical at a time. One possible approach to tackle MRA could be to cluster DNT chemicals in a mixture on the basis of their mode of action (MoA) into \u2018similar\u2019 and \u2018dissimilar\u2019, but still contributing to the same adverse outcome, and anchor DNT assays to common key events (CKEs) identified in DNT-specific adverse outcome pathways (AOPs). Moreover, the use of human in vitro models, such as induced pluripotent stem cell (hiPSC)-derived neuronal and glial cultures would enable mechanistic understanding of chemically-induced adverse effects, avoiding species extrapolation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>HiPSC-derived neural progenitors differentiated into mixed cultures of neurons and astrocytes were used to assess the effects of acute (3\u2009days) and repeated dose (14\u2009days) treatments with single chemicals and in mixtures belonging to different classes (i.e., lead(II) chloride and methylmercury chloride (heavy metals), chlorpyrifos (pesticide), bisphenol A (organic compound and endocrine disrupter), valproic acid (drug), and PCB138 (persistent organic pollutant and endocrine disrupter), which are associated with cognitive deficits, including learning and memory impairment in children. Selected chemicals were grouped based on their mode of action (MoA) into \u2018similar\u2019 and \u2018dissimilar\u2019 MoA compounds and their effects on synaptogenesis, neurite outgrowth, and brain derived neurotrophic factor (BDNF) protein levels, identified as CKEs in currently available AOPs relevant to DNT, were evaluated by immunocytochemistry and high content imaging analysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Chemicals working through similar MoA (i.e., alterations of BDNF levels), at\u00a0non-cytotoxic (IC<jats:sub>20<\/jats:sub>\/100), very low toxic (IC<jats:sub>5<\/jats:sub>), or moderately toxic (IC<jats:sub>20<\/jats:sub>)\u00a0concentrations, induce DNT effects in mixtures, as shown by increased number of neurons, impairment of neurite outgrowth and synaptogenesis (the most sensitive endpoint as confirmed by mathematical modelling) and increase of BDNF levels, to a certain extent reproducing autism-like cellular changes observed in the brain of autistic children.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our findings suggest that the use of human iPSC-derived mixed neuronal\/glial cultures applied to a battery of assays anchored to key events of an AOP network represents a valuable approach to identify mixtures of chemicals with potential to cause learning and memory impairment in children.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12940-020-00578-x","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T08:05:47Z","timestamp":1582531547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept"],"prefix":"10.1186","volume":"19","author":[{"given":"Francesca","family":"Pistollato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio Mendoza","family":"de Gyves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Carpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie K.","family":"Bopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-0043","authenticated-orcid":false,"given":"Anna","family":"Bal-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"issue":"3","key":"578_CR1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1474-4422(13)70278-3","volume":"13","author":"P Grandjean","year":"2014","unstructured":"Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014;13(3):330\u20138.","journal-title":"Lancet Neurol"},{"issue":"5","key":"578_CR2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/jech-2014-203980","volume":"69","author":"MV Maffini","year":"2015","unstructured":"Maffini MV, Neltner TG. Brain drain: the cost of neglected responsibilities in evaluating cumulative effects of environmental chemicals. J Epidemiol Community Health. 2015;69(5):496\u20139.","journal-title":"J Epidemiol Community Health"},{"issue":"Pt A","key":"578_CR3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.scitotenv.2015.10.162","volume":"543","author":"RM Evans","year":"2016","unstructured":"Evans RM, Martin OV, Faust M, Kortenkamp A. Should the scope of human mixture risk assessment span legislative\/regulatory silos for chemicals? Sci Total Environ. 2016;543(Pt A):757\u201364.","journal-title":"Sci Total Environ"},{"issue":"10","key":"578_CR4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.chemosphere.2010.09.079","volume":"81","author":"M Schlumpf","year":"2010","unstructured":"Schlumpf M, Kypke K, Wittassek M, Angerer J, Mascher H, Mascher D, Vokt C, Birchler M, Lichtensteiger W. Exposure patterns of UV filters, fragrances, parabens, phthalates, organochlor pesticides, PBDEs, and PCBs in human milk: correlation of UV filters with use of cosmetics. Chemosphere. 2010;81(10):1171\u201383.","journal-title":"Chemosphere"},{"key":"578_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1476-069X-13-106","volume":"13","author":"M de Cock","year":"2014","unstructured":"de Cock M, de Boer MR, Lamoree M, Legler J, van de Bor M. Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants - a Dutch prospective cohort study. Environ Health. 2014;13:106.","journal-title":"Environ Health"},{"key":"578_CR6","doi-asserted-by":"crossref","unstructured":"EFSA: PPR Panel: Scientific Opinion on the relevance of dissimilar mode of action and its appropriate application for cumulative risk assessment of pesticides residues in food. . In: EFSA Journal 2013. vol. 11; 2013: 40.","DOI":"10.2903\/j.efsa.2013.3472"},{"key":"578_CR7","unstructured":"EFSA: Scientific Committee: Draft guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals In., vol. EFSA Journal 2019;17(3):5634: EFSA; 2019: 77."},{"issue":"Suppl 1","key":"578_CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1289\/ehp.9357","volume":"115","author":"A Kortenkamp","year":"2007","unstructured":"Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect. 2007;115(Suppl 1):98\u2013105.","journal-title":"Environ Health Perspect"},{"key":"578_CR9","unstructured":"AOP 54: Inhibition of Na+\/I- symporter (NIS) leads to learning and memory impairment. https:\/\/aopwiki.org\/aops\/54. Accessed 14 May 2019."},{"key":"578_CR10","unstructured":"AOP 42: Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals. https:\/\/aopwiki.org\/aops\/42. Accessed 14 May 2019."},{"key":"578_CR11","unstructured":"AOP 134: Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals. https:\/\/aopwiki.org\/aops\/134. Accessed 14 May 2019."},{"key":"578_CR12","unstructured":"AOP 13: Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities. https:\/\/aopwiki.org\/aops\/13. Accessed 14 May 2019."},{"key":"578_CR13","unstructured":"AOP 12: Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging. https:\/\/aopwiki.org\/aops\/12. Accessed 14 May 2019."},{"issue":"1","key":"578_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10408444.2014.981331","volume":"45","author":"A Bal-Price","year":"2015","unstructured":"Bal-Price A, Crofton KM, Sachana M, Shafer TJ, Behl M, Forsby A, Hargreaves A, Landesmann B, Lein PJ, Louisse J, et al. Putative adverse outcome pathways relevant to neurotoxicity. Crit Rev Toxicol. 2015;45(1):83\u201391.","journal-title":"Crit Rev Toxicol"},{"issue":"6","key":"578_CR15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/risa.12425","volume":"35","author":"K von Stackelberg","year":"2015","unstructured":"von Stackelberg K, Guzy E, Chu T, Claus Henn B. Exposure to mixtures of metals and neurodevelopmental outcomes: a multidisciplinary review using an adverse outcome pathway framework. Risk Anal. 2015;35(6):971\u20131016.","journal-title":"Risk Anal"},{"key":"578_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2017.05.006","volume":"179","author":"A Bal-Price","year":"2017","unstructured":"Bal-Price A, Meek MEB. Adverse outcome pathways: application to enhance mechanistic understanding of neurotoxicity. Pharmacol Ther. 2017;179:84\u201395.","journal-title":"Pharmacol Ther"},{"key":"578_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.taap.2018.02.024","volume":"354","author":"M Sachana","year":"2018","unstructured":"Sachana M, Rolaki A, Bal-Price A. Development of the adverse outcome pathway (AOP): chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children. Toxicol Appl Pharmacol. 2018;354:153\u201375.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"578_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/gbb.12255","volume":"15","author":"DE Ehrlich","year":"2016","unstructured":"Ehrlich DE, Josselyn SA. Plasticity-related genes in brain development and amygdala-dependent learning. Genes Brain Behav. 2016;15(1):125\u201343.","journal-title":"Genes Brain Behav"},{"issue":"1","key":"578_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/toxsci\/kfq111","volume":"116","author":"AP Neal","year":"2010","unstructured":"Neal AP, Stansfield KH, Worley PF, Thompson RE, Guilarte TR. Lead exposure during synaptogenesis alters vesicular proteins and impairs vesicular release: potential role of NMDA receptor-dependent BDNF signaling. Toxicol Sci. 2010;116(1):249\u201363.","journal-title":"Toxicol Sci"},{"key":"578_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13041-016-0203-9","volume":"9","author":"J Gibon","year":"2016","unstructured":"Gibon J, Barker PA, Seguela P. Opposing presynaptic roles of BDNF and ProBDNF in the regulation of persistent activity in the entorhinal cortex. Mol Brain. 2016;9:23.","journal-title":"Mol Brain"},{"issue":"2","key":"578_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/toxsci\/kfm248","volume":"100","author":"AM Betancourt","year":"2007","unstructured":"Betancourt AM, Filipov NM, Carr RL. Alteration of neurotrophins in the hippocampus and cerebral cortex of young rats exposed to chlorpyrifos and methyl parathion. Toxicol Sci. 2007;100(2):445\u201355.","journal-title":"Toxicol Sci"},{"issue":"1","key":"578_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuro.2004.07.008","volume":"26","author":"L Imamura","year":"2005","unstructured":"Imamura L, Kurashina K, Kawahira T, Omoteno M, Tsuda M. Additional repression of activity-dependent c-fos and BDNF mRNA expression by lipophilic compounds accompanying a decrease in Ca2+ influx into neurons. Neurotoxicology. 2005;26(1):17\u201325.","journal-title":"Neurotoxicology"},{"key":"578_CR23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2016.01.001","volume":"340","author":"YS Lee","year":"2016","unstructured":"Lee YS, Lewis JA, Ippolito DL, Hussainzada N, Lein PJ, Jackson DA, Stallings JD. Repeated exposure to neurotoxic levels of chlorpyrifos alters hippocampal expression of neurotrophins and neuropeptides. Toxicology. 2016;340:53\u201362.","journal-title":"Toxicology"},{"issue":"1\u20133","key":"578_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tox.2012.03.007","volume":"296","author":"YJ Jang","year":"2012","unstructured":"Jang YJ, Park HR, Kim TH, Yang WJ, Lee JJ, Choi SY, Oh SB, Lee E, Park JH, Kim HP, et al. High dose bisphenol a impairs hippocampal neurogenesis in female mice across generations. Toxicology. 2012;296(1\u20133):73\u201382.","journal-title":"Toxicology"},{"key":"578_CR25","doi-asserted-by":"crossref","first-page":"654085","DOI":"10.1155\/2011\/654085","volume":"2011","author":"PS Murray","year":"2011","unstructured":"Murray PS, Holmes PV. An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus. Int J Pept. 2011;2011:654085.","journal-title":"Int J Pept"},{"issue":"4","key":"578_CR26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.brainresbull.2008.01.001","volume":"76","author":"TA Slotkin","year":"2008","unstructured":"Slotkin TA, Seidler FJ, Fumagalli F. Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro. Brain Res Bull. 2008;76(4):424\u201338.","journal-title":"Brain Res Bull"},{"issue":"1","key":"578_CR27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/toxsci\/kfs090","volume":"127","author":"KH Stansfield","year":"2012","unstructured":"Stansfield KH, Pilsner JR, Lu Q, Wright RO, Guilarte TR. Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2+): implications for an environmental basis of neurodevelopmental disorders. Toxicol Sci. 2012;127(1):277\u201395.","journal-title":"Toxicol Sci"},{"issue":"1","key":"578_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.etap.2015.06.010","volume":"40","author":"T Takemoto","year":"2015","unstructured":"Takemoto T, Ishihara Y, Ishida A, Yamazaki T. Neuroprotection elicited by nerve growth factor and brain-derived neurotrophic factor released from astrocytes in response to methylmercury. Environ Toxicol Pharmacol. 2015;40(1):199\u2013205.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"578_CR29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/aivt.2015.0025","volume":"2","author":"I Druwe","year":"2016","unstructured":"Druwe I, Freudenrich T, Wallace K, Shafer T, Mundy W. Comparison of human induced pluripotent stem cell-derived neurons and rat primary cortical neurons as in vitro models of neurite outgrowth. Applied In Vitro Toxicol. 2016;2(1):26\u201336.","journal-title":"Applied In Vitro Toxicol"},{"issue":"1","key":"578_CR30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tiv.2010.10.011","volume":"25","author":"JA Harrill","year":"2011","unstructured":"Harrill JA, Robinette BL, Mundy WR. Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro. Toxicol in Vitro. 2011;25(1):368\u201387.","journal-title":"Toxicol in Vitro"},{"issue":"2\u20133","key":"578_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.tox.2010.02.004","volume":"270","author":"WR Mundy","year":"2010","unstructured":"Mundy WR, Radio NM, Freudenrich TM. Neuronal models for evaluation of proliferation in vitro using high content screening. Toxicology. 2010;270(2\u20133):121\u201330.","journal-title":"Toxicology"},{"key":"578_CR32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neuro.2016.02.003","volume":"53","author":"KR Ryan","year":"2016","unstructured":"Ryan KR, Sirenko O, Parham F, Hsieh JH, Cromwell EF, Tice RR, Behl M. Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity. Neurotoxicology. 2016;53:271\u201381.","journal-title":"Neurotoxicology"},{"key":"578_CR33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.taap.2018.04.001","volume":"354","author":"JA Harrill","year":"2018","unstructured":"Harrill JA, Freudenrich T, Wallace K, Ball K, Shafer TJ, Mundy WR. Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment. Toxicol Appl Pharmacol. 2018;354:24\u201339.","journal-title":"Toxicol Appl Pharmacol"},{"key":"578_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.taap.2018.02.008","volume":"354","author":"A Bal-Price","year":"2018","unstructured":"Bal-Price A, Pistollato F, Sachana M, Bopp SK, Munn S, Worth A. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods. Toxicol Appl Pharmacol. 2018;354:7\u201318.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2015","key":"578_CR35","first-page":"1","volume":"EN-778","author":"E Fritsche","year":"2015","unstructured":"Fritsche E, Alm H, Baumann J, Geerts L, H\u00e5kansson H, Masjosthusmann S, Witters H. Literature review on in vitro and alternative developmental neurotoxicity (DNT) testing methods. EFSA Support Publ. 2015;EN-778(2015):1\u2013186.","journal-title":"EFSA Support Publ"},{"issue":"3","key":"578_CR36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.14573\/altex.1712081","volume":"35","author":"A Bal-Price","year":"2018","unstructured":"Bal-Price A, Hogberg HT, Crofton KM, Daneshian M, FitzGerald RE, Fritsche E, Heinonen T, Hougaard Bennekou S, Klima S, Piersma AH, et al. Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicity. ALTEX. 2018;35(3):306\u201352.","journal-title":"ALTEX"},{"issue":"2","key":"578_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00204-015-1464-2","volume":"89","author":"A Bal-Price","year":"2015","unstructured":"Bal-Price A, Crofton KM, Leist M, Allen S, Arand M, Buetler T, Delrue N, FitzGerald RE, Hartung T, Heinonen T, et al. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch Toxicol. 2015;89(2):269\u201387.","journal-title":"Arch Toxicol"},{"key":"578_CR38","doi-asserted-by":"crossref","unstructured":"Pistollato F, Canovas-Jorda D, Zagoura D, Price A. Protocol for the differentiation of human induced pluripotent stem cells into mixed cultures of neurons and glia for neurotoxicity testing. J Vis Exp. 2017;(124):55702.","DOI":"10.3791\/55702"},{"key":"578_CR39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuint.2016.09.004","volume":"106","author":"D Zagoura","year":"2017","unstructured":"Zagoura D, Canovas-Jorda D, Pistollato F, Bremer-Hoffmann S, Bal-Price A. Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells. Neurochem Int. 2017;106:62\u201373.","journal-title":"Neurochem Int"},{"issue":"9","key":"578_CR40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00204-006-0091-3","volume":"80","author":"PJ O'Brien","year":"2006","unstructured":"O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, Gao B, Kaludercic N, Angeline A, Bernardi P, et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol. 2006;80(9):580\u2013604.","journal-title":"Arch Toxicol"},{"key":"578_CR41","unstructured":"Update: use of the benchmark dose approach in risk assessment. https:\/\/efsa.onlinelibrary.wiley.com\/doi\/epdf\/10.2903\/j.efsa.2017.4658. Accessed 3 Dec 2019."},{"key":"578_CR42","unstructured":"Toxicity and Assessment of Chemical Mixtures. https:\/\/ec.europa.eu\/health\/scientific_committees\/environmental_risks\/docs\/scher_o_155.pdf. Accessed 3 Dec 2019."},{"key":"578_CR43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.envint.2019.01.059","volume":"127","author":"H Wang","year":"2019","unstructured":"Wang H, Chang L, Aguilar JS, Dong S, Hong Y. Bisphenol-a exposure induced neurotoxicity in glutamatergic neurons derived from human embryonic stem cells. Environ Int. 2019;127:324\u201332.","journal-title":"Environ Int"},{"issue":"5","key":"578_CR44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5607\/en.2017.26.5.252","volume":"26","author":"KC Kim","year":"2017","unstructured":"Kim KC, Choi CS, Gonzales ELT, Mabunga DFN, Lee SH, Jeon SJ, Hwangbo R, Hong M, Ryu JH, Han SH, et al. Valproic acid induces telomerase reverse transcriptase expression during cortical development. Exp Neurobiol. 2017;26(5):252\u201365.","journal-title":"Exp Neurobiol"},{"key":"578_CR45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tox.2016.10.014","volume":"373","author":"M Gassowska","year":"2016","unstructured":"Gassowska M, Baranowska-Bosiacka I, Moczydlowska J, Frontczak-Baniewicz M, Gewartowska M, Struzynska L, Gutowska I, Chlubek D, Adamczyk A. Perinatal exposure to lead (Pb) induces ultrastructural and molecular alterations in synapses of rat offspring. Toxicology. 2016;373:13\u201329.","journal-title":"Toxicology"},{"issue":"2","key":"578_CR46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/taap.2002.9445","volume":"182","author":"RA Schuh","year":"2002","unstructured":"Schuh RA, Lein PJ, Beckles RA, Jett DA. Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+\/cAMP response element binding protein in cultured neurons. Toxicol Appl Pharmacol. 2002;182(2):176\u201385.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"578_CR47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/taap.1999.8767","volume":"160","author":"KP Das","year":"1999","unstructured":"Das KP, Barone S Jr. Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterase inhibition the site of action? Toxicol Appl Pharmacol. 1999;160(3):217\u201330.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"578_CR48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.taap.2004.12.008","volume":"207","author":"AS Howard","year":"2005","unstructured":"Howard AS, Bucelli R, Jett DA, Bruun D, Yang D, Lein PJ. Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures. Toxicol Appl Pharmacol. 2005;207(2):112\u201324.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"578_CR49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mutage\/get019","volume":"28","author":"S Ermler","year":"2013","unstructured":"Ermler S, Scholze M, Kortenkamp A. Seven benzimidazole pesticides combined at sub-threshold levels induce micronuclei in vitro. Mutagenesis. 2013;28(4):417\u201326.","journal-title":"Mutagenesis"},{"issue":"11","key":"578_CR50","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/cns.12445","volume":"21","author":"ZM Long","year":"2015","unstructured":"Long ZM, Zhao L, Jiang R, Wang KJ, Luo SF, Zheng M, Li XF, He GQ. Valproic acid modifies synaptic structure and accelerates Neurite outgrowth via the glycogen synthase kinase-3beta signaling pathway in an Alzheimer's disease model. CNS Neurosci Ther. 2015;21(11):887\u201397.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"578_CR51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjc.6602309","volume":"92","author":"MT Stockhausen","year":"2005","unstructured":"Stockhausen MT, Sjolund J, Manetopoulos C, Axelson H. Effects of the histone deacetylase inhibitor valproic acid on notch signalling in human neuroblastoma cells. Br J Cancer. 2005;92(4):751\u20139.","journal-title":"Br J Cancer"},{"issue":"18","key":"578_CR52","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.2011.1638","volume":"306","author":"E Courchesne","year":"2011","unstructured":"Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, Pierce K. Neuron number and size in prefrontal cortex of children with autism. JAMA. 2011;306(18):2001\u201310.","journal-title":"JAMA"},{"key":"578_CR53","first-page":"24","volume":"16","author":"HTN Nguyen","year":"2018","unstructured":"Nguyen HTN, Kato H, Masuda K, Yamaza H, Hirofuji Y, Sato H, Pham TTM, Takayama F, Sakai Y, Ohga S, et al. Impaired neurite development associated with mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous tooth-derived pulp stem cells of children with autism spectrum disorder. Biochem Biophys Rep. 2018;16:24\u201331.","journal-title":"Biochem Biophys Rep"},{"issue":"7","key":"578_CR54","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1038\/tp.2017.144","volume":"7","author":"J Nagy","year":"2017","unstructured":"Nagy J, Kobolak J, Berzsenyi S, Abraham Z, Avci HX, Bock I, Bekes Z, Hodoscsek B, Chandrasekaran A, Teglasi A, et al. Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autism. Transl Psychiatry. 2017;7(7):e1179.","journal-title":"Transl Psychiatry"},{"key":"578_CR55","first-page":"397","volume":"8","author":"EL Casanova","year":"2014","unstructured":"Casanova EL, Casanova MF. Genetics studies indicate that neural induction and early neuronal maturation are disturbed in autism. Front Cell Neurosci. 2014;8:397.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"578_CR56","first-page":"237","volume":"25","author":"T Numakawa","year":"2010","unstructured":"Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H. BDNF function and intracellular signaling in neurons. Histol Histopathol. 2010;25(2):237\u201358.","journal-title":"Histol Histopathol"},{"issue":"6","key":"578_CR57","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0896-6273(00)80140-3","volume":"16","author":"SL Patterson","year":"1996","unstructured":"Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 1996;16(6):1137\u201345.","journal-title":"Neuron"},{"issue":"4","key":"578_CR58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejpn.2015.03.005","volume":"19","author":"V Bryn","year":"2015","unstructured":"Bryn V, Halvorsen B, Ueland T, Isaksen J, Kolkova K, Ravn K, Skjeldal OH. Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood. Eur J Paediatr Neurol. 2015;19(4):411\u20134.","journal-title":"Eur J Paediatr Neurol"},{"key":"578_CR59","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbr.2018.06.023","volume":"359","author":"G Maussion","year":"2019","unstructured":"Maussion G, Moalic JM, Simonneau M, Gorwood P, Ramoz N. Increased expression of BDNF mRNA in the frontal cortex of autistic patients. Behav Brain Res. 2019;359:903\u20139.","journal-title":"Behav Brain Res"},{"issue":"4","key":"578_CR60","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s10803-016-3024-x","volume":"47","author":"A Saghazadeh","year":"2017","unstructured":"Saghazadeh A, Rezaei N. Brain-derived Neurotrophic factor levels in autism: a systematic review and meta-analysis. J Autism Dev Disord. 2017;47(4):1018\u201329.","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"578_CR61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10571-016-0415-7","volume":"37","author":"R Armeanu","year":"2017","unstructured":"Armeanu R, Mokkonen M, Crespi B. Meta-analysis of BDNF levels in autism. Cell Mol Neurobiol. 2017;37(5):949\u201354.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"578_CR62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/toxsci\/kfm027","volume":"97","author":"GD Lyng","year":"2007","unstructured":"Lyng GD, Snyder-Keller A, Seegal RF. Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum. Toxicol Sci. 2007;97(1):128\u201339.","journal-title":"Toxicol Sci"},{"issue":"2","key":"578_CR63","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.neuro.2008.12.009","volume":"30","author":"G Giordano","year":"2009","unstructured":"Giordano G, Kavanagh TJ, Costa LG. Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. Neurotoxicology. 2009;30(2):326\u20139.","journal-title":"Neurotoxicology"},{"issue":"2","key":"578_CR64","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/toxsci\/kfq266","volume":"118","author":"A Rai","year":"2010","unstructured":"Rai A, Maurya SK, Khare P, Srivastava A, Bandyopadhyay S. Characterization of developmental neurotoxicity of as, cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions. Toxicol Sci. 2010;118(2):586\u2013601.","journal-title":"Toxicol Sci"},{"issue":"1\u20132","key":"578_CR65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tox.2012.11.016","volume":"311","author":"O Cauli","year":"2013","unstructured":"Cauli O, Piedrafita B, Llansola M, Felipo V. Gender differential effects of developmental exposure to methyl-mercury, polychlorinated biphenyls 126 or 153, or its combinations on motor activity and coordination. Toxicology. 2013;311(1\u20132):61\u20138.","journal-title":"Toxicology"},{"issue":"1","key":"578_CR66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2007.05.018","volume":"238","author":"T Coccini","year":"2007","unstructured":"Coccini T, Roda E, Castoldi AF, Goldoni M, Poli D, Bernocchi G, Manzo L. Perinatal co-exposure to methylmercury and PCB153 or PCB126 in rats alters the cerebral cholinergic muscarinic receptors at weaning and puberty. Toxicology. 2007;238(1):34\u201348.","journal-title":"Toxicology"},{"issue":"1","key":"578_CR67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1741-4520.2012.00381.x","volume":"53","author":"K Warita","year":"2013","unstructured":"Warita K, Mitsuhashi T, Ohta K, Suzuki S, Hoshi N, Miki T, Takeuchi Y. In vitro evaluation of gene expression changes for gonadotropin-releasing hormone 1, brain-derived neurotrophic factor and neurotrophic tyrosine kinase, receptor, type 2, in response to bisphenol a treatment. Congenit Anom (Kyoto). 2013;53(1):42\u20135.","journal-title":"Congenit Anom (Kyoto)"},{"issue":"1","key":"578_CR68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cbi.2011.08.001","volume":"194","author":"S Seki","year":"2011","unstructured":"Seki S, Aoki M, Hosokawa T, Saito T, Masuma R, Komori M, Kurasaki M. Bisphenol-a suppresses neurite extension due to inhibition of phosphorylation of mitogen-activated protein kinase in PC12 cells. Chem Biol Interact. 2011;194(1):23\u201330.","journal-title":"Chem Biol Interact"},{"issue":"2","key":"578_CR69","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.111.184762","volume":"339","author":"ML Middlemore-Risher","year":"2011","unstructured":"Middlemore-Risher ML, Adam BL, Lambert NA, Terry AV Jr. Effects of chlorpyrifos and chlorpyrifos-oxon on the dynamics and movement of mitochondria in rat cortical neurons. J Pharmacol Exp Ther. 2011;339(2):341\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"578_CR70","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/tx900440q","volume":"23","author":"M Llansola","year":"2010","unstructured":"Llansola M, Montoliu C, Boix J, Felipo V. Polychlorinated biphenyls PCB 52, PCB 180, and PCB 138 impair the glutamate-nitric oxide-cGMP pathway in cerebellar neurons in culture by different mechanisms. Chem Res Toxicol. 2010;23(4):813\u201320.","journal-title":"Chem Res Toxicol"},{"key":"578_CR71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.scitotenv.2017.12.023","volume":"624","author":"RP Sharma","year":"2018","unstructured":"Sharma RP, Schuhmacher M, Kumar V. The development of a pregnancy PBPK model for Bisphenol a and its evaluation with the available biomonitoring data. Sci Total Environ. 2018;624:55\u201368.","journal-title":"Sci Total Environ"},{"issue":"2","key":"578_CR72","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/10408444.2019.1579169","volume":"49","author":"Stephanie K. Bopp","year":"2019","unstructured":"Bopp SK, Kienzler A, Richarz AN, van der Linden SC, Paini A, Parissis N, Worth AP. Regulatory assessment and risk management of chemical mixtures: challenges and ways forward. Crit Rev Toxicol. 2019:49(2):174\u2013189.","journal-title":"Critical Reviews in Toxicology"},{"issue":"10","key":"578_CR73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cppeds.2014.06.001","volume":"44","author":"AE Kalkbrenner","year":"2014","unstructured":"Kalkbrenner AE, Schmidt RJ, Penlesky AC. Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr Probl Pediatr Adolesc Health Care. 2014;44(10):277\u2013318.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"578_CR74","unstructured":"Developmental Neurotoxicity Study (OECD TG 426). https:\/\/http:\/\/www.oecd-ilibrary.org\/environment\/revised-guidance-document-150-on-standardised-test-guidelines-for-evaluating-chemicals-for-endocrine-disruption\/developmental-neurotoxicity-study-oecd-tg-426_9789264304741-27-en. Accessed 15 May 2019."},{"key":"578_CR75","volume-title":"PPR Panel: Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid","author":"1","year":"2013","unstructured":"1: PPR Panel: Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid 2013."},{"issue":"5","key":"578_CR76","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ntt.2010.04.053","volume":"32","author":"KC Raffaele","year":"2010","unstructured":"Raffaele KC, Rowland J, May B, Makris SL, Schumacher K, Scarano LJ. The use of developmental neurotoxicity data in pesticide risk assessments. Neurotoxicol Teratol. 2010;32(5):563\u201372.","journal-title":"Neurotoxicol Teratol"},{"key":"578_CR77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.taap.2018.02.004","volume":"354","author":"E Fritsche","year":"2018","unstructured":"Fritsche E, Grandjean P, Crofton KM, Aschner M, Goldberg A, Heinonen T, Hessel EVS, Hogberg HT, Bennekou SH, Lein PJ, et al. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes. Toxicol Appl Pharmacol. 2018;354:3\u20136.","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12940-020-00578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12940-020-00578-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12940-020-00578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:30:35Z","timestamp":1614040235000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehjournal.biomedcentral.com\/articles\/10.1186\/s12940-020-00578-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1186\/s12940-020-00578-x","relation":{},"ISSN":["1476-069X"],"issn-type":[{"value":"1476-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"13 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}